Balaxi Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 827.85 million compared to INR 583.35 million a year ago. Revenue was INR 860.69 million compared to INR 595.08 million a year ago. Net income was INR 141.47 million compared to INR 107.14 million a year ago. Basic earnings per share from continuing operations was INR 14.15 compared to INR 10.71 a year ago. Diluted earnings per share from continuing operations was INR 14.15 compared to INR 10.71 a year ago.